PL1954308T3 - Stabilizatory do liofilizowanych szczepionek - Google Patents
Stabilizatory do liofilizowanych szczepionekInfo
- Publication number
- PL1954308T3 PL1954308T3 PL06814694T PL06814694T PL1954308T3 PL 1954308 T3 PL1954308 T3 PL 1954308T3 PL 06814694 T PL06814694 T PL 06814694T PL 06814694 T PL06814694 T PL 06814694T PL 1954308 T3 PL1954308 T3 PL 1954308T3
- Authority
- PL
- Poland
- Prior art keywords
- stabilizers
- freeze
- live attenuated
- present
- dried vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 239000003381 stabilizer Substances 0.000 title abstract 3
- 241000282465 Canis Species 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71764005P | 2005-09-16 | 2005-09-16 | |
PCT/US2006/035944 WO2007035455A2 (en) | 2005-09-16 | 2006-09-15 | Stabilizers for freeze-dried vaccines |
EP06814694A EP1954308B1 (en) | 2005-09-16 | 2006-09-15 | Stabilizers for freeze-dried vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1954308T3 true PL1954308T3 (pl) | 2012-01-31 |
Family
ID=37808009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06814694T PL1954308T3 (pl) | 2005-09-16 | 2006-09-15 | Stabilizatory do liofilizowanych szczepionek |
Country Status (15)
Country | Link |
---|---|
US (1) | US8784843B2 (pl) |
EP (1) | EP1954308B1 (pl) |
JP (1) | JP5275803B2 (pl) |
CN (1) | CN101312742B (pl) |
AT (1) | ATE523207T1 (pl) |
CY (1) | CY1112490T1 (pl) |
DK (1) | DK1954308T3 (pl) |
ES (1) | ES2373238T3 (pl) |
HR (1) | HRP20110803T1 (pl) |
ME (1) | ME01965B (pl) |
PL (1) | PL1954308T3 (pl) |
PT (1) | PT1954308E (pl) |
RS (1) | RS51996B (pl) |
SI (1) | SI1954308T1 (pl) |
WO (1) | WO2007035455A2 (pl) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8168206B1 (en) | 2005-10-06 | 2012-05-01 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
US8137677B2 (en) * | 2005-10-06 | 2012-03-20 | Allergan, Inc. | Non-protein stabilized clostridial toxin pharmaceutical compositions |
DK1973406T3 (da) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corp | Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
US9642907B2 (en) * | 2006-05-12 | 2017-05-09 | Bharat Biotech International Limited | Stabilized liquid rotavirus vaccine composition |
WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
NZ585877A (en) * | 2007-12-21 | 2012-06-29 | Pfizer | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
GB0823497D0 (en) | 2008-12-24 | 2009-01-28 | Isis Innovation | Immunogenic composition and use thereof |
CN102459578A (zh) * | 2009-01-30 | 2012-05-16 | 俄克拉荷马州大学评议会 | 基于在北美狗中循环的犬瘟热病毒的免疫原性组合物、疫苗和诊断方法 |
WO2010111565A2 (en) | 2009-03-27 | 2010-09-30 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
CN106987525B (zh) | 2009-05-26 | 2020-10-27 | 先进生物营养公司 | 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法 |
WO2011094469A2 (en) | 2010-01-28 | 2011-08-04 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
DK2898890T3 (da) * | 2010-03-31 | 2019-11-25 | Stabilitech Biopharma Ltd | Stabilisering af viruspartikler |
HUE033656T2 (en) | 2010-03-31 | 2017-12-28 | Stabilitech Ltd | Binders for stabilizing virus particles |
JP5771626B2 (ja) | 2010-04-15 | 2015-09-02 | 株式会社新日本科学 | 鼻内送達のための方法および組成物 |
JP5727611B2 (ja) | 2010-08-13 | 2015-06-03 | アドバンスド バイオニュートリション コーポレイション | 生体物質用の乾燥貯蔵安定化組成物 |
US9173933B2 (en) * | 2010-10-15 | 2015-11-03 | Bavarian Nordic A/S | Recombinant modified vaccinia virus Ankara influenza vaccine |
JP6034798B2 (ja) | 2010-12-02 | 2016-11-30 | オンコリティクス バイオテク,インコーポレーテッド | 液体ウイルス製剤 |
US9044498B2 (en) * | 2010-12-02 | 2015-06-02 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
CN102228687B (zh) * | 2011-06-24 | 2012-10-10 | 浙江普康生物技术股份有限公司 | 不含明胶、人血白蛋白保护剂的冷冻干燥甲型肝炎减毒活疫苗及制备方法 |
BR112014001287B1 (pt) * | 2011-07-20 | 2020-12-08 | Centre National De La Recherche Scientifique | vacina recombinante do vírus da leucemia felina contendo gene otimizado do envelope do vírus da leucemia felina |
WO2013025274A1 (en) * | 2011-08-12 | 2013-02-21 | Merial Limited | Vacuum -assisted preservation of biological products, in particular of vaccines |
GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
US20150044251A1 (en) * | 2011-12-23 | 2015-02-12 | Novartis Ag | Stable compositions for immunising against staphylococcus aureus |
CN102488894B (zh) * | 2011-12-31 | 2014-08-20 | 齐鲁动物保健品有限公司 | 一种狐狸脑炎活疫苗及其制备方法 |
US9314519B2 (en) * | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
CN102854313A (zh) * | 2012-09-29 | 2013-01-02 | 黑龙江省农业科学院植物脱毒苗木研究所 | 马铃薯y病毒阳性对照品的制备方法 |
CN102920669A (zh) * | 2012-11-09 | 2013-02-13 | 湖北凤凰白云山药业有限公司 | 一种甘露醇冻干粉的制备方法 |
US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
US9480739B2 (en) | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
ES2897659T3 (es) | 2013-09-03 | 2022-03-02 | Georgia Tech Res Inst | Formulaciones de vacunas térmicamente estables, procesos y microagujas que incluyen las formulaciones de vacunas |
AR097762A1 (es) * | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
CA2926696A1 (en) * | 2013-10-16 | 2015-04-23 | Merck Sharp & Dohme Corp | Thermostable respiratory synctial virus (rsv) vaccine compositions |
WO2015057540A1 (en) | 2013-10-16 | 2015-04-23 | Merck Sharp & Dohme Corp. | Method of microwave vacuum drying spherical-shaped pellets of biological materials |
AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
FR3034418B1 (fr) * | 2015-04-03 | 2018-09-28 | Roquette Freres | Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons |
CN108347982A (zh) | 2015-07-29 | 2018-07-31 | 高级生物营养公司 | 用于特殊饮食用途的稳定的干燥益生菌组合物 |
US10617650B2 (en) | 2015-10-16 | 2020-04-14 | Merck Sharp & Dohme Corp. | Process for preparing formulations for gastrointestinal-targeted therapies |
KR20240023684A (ko) | 2016-09-13 | 2024-02-22 | 알레간 인코포레이티드 | 안정화된 비단백질 클로스트리듐 독소 조성물 |
NL2018155B1 (en) | 2017-01-11 | 2018-07-25 | Intervet Int Bv | Oral vaccine against ruminant respiratory disease |
GB201701239D0 (en) | 2017-01-25 | 2017-03-08 | Glaxosmithkline Biologicals Sa | Novel formulation |
GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
US20210223262A1 (en) * | 2018-06-07 | 2021-07-22 | Merck Sharp & Dohme Corp. | Lyosphere critical reagent kit |
CN109652384B (zh) * | 2019-02-21 | 2021-10-26 | 昆明理工大学 | 一种体外培养戊型肝炎病毒的方法 |
CN111707512A (zh) * | 2020-06-15 | 2020-09-25 | 深圳市瑞赛生物技术有限公司 | 即用型维生素标准品及其制备方法、使用方法和贮存稳定剂 |
CN112057603B (zh) * | 2020-07-25 | 2023-07-14 | 艾美卫信生物药业(浙江)有限公司 | 一种白喉毒素无毒突变体crm197蛋白的冻干方法 |
CN115624630A (zh) * | 2022-12-19 | 2023-01-20 | 北京荷牧生物科技有限公司 | 冻干保护组合物及其应用和基于该组合物的核酸脂质纳米颗粒冻存方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1108956A (en) * | 1964-05-26 | 1968-04-10 | Ciba Ltd | Process for the manufacture of bcg vaccines |
US3783098A (en) * | 1971-08-10 | 1974-01-01 | Cornell Res Foundation Inc | Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same |
JPS4840990A (pl) * | 1971-10-04 | 1973-06-15 | ||
FR2505657A1 (fr) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
JPS6281327A (ja) * | 1985-10-04 | 1987-04-14 | Green Cross Corp:The | 人トロンビン製剤の加熱処理方法 |
JPH07121871B2 (ja) * | 1986-10-09 | 1995-12-25 | 国立予防衛生研究所長 | インフルエンザワクチン凍結乾燥製剤 |
US4888169A (en) * | 1986-10-14 | 1989-12-19 | Norden Laboratories, Inc. | Bordetella Bronchiseptica vaccine |
US5147756A (en) * | 1991-04-11 | 1992-09-15 | E. I. Du Pont De Nemours And Company | Stabilized, aqueous hydrazide solutions for photographic elements |
CA2075521C (en) * | 1992-05-05 | 1995-11-28 | Kuniaki Koyama | Stabilized live vaccine |
EP0728195A1 (en) * | 1993-10-12 | 1996-08-28 | Chiron Corporation | Methods for preserving recombinant viruses |
JPH08176011A (ja) * | 1994-12-21 | 1996-07-09 | Dot:Kk | 無菌性骨壊死症候群治療剤 |
AU4954496A (en) * | 1995-03-17 | 1996-10-08 | Hisamitsu Pharmaceutical Co., Inc. | Gene transfer preparation |
JP3193057B2 (ja) * | 1995-03-17 | 2001-07-30 | 久光製薬株式会社 | 遺伝子導入製剤 |
JPH08333277A (ja) * | 1995-06-05 | 1996-12-17 | Hoechst Japan Ltd | ヒト血液凝固第xiii因子の安定化された水性液製剤 |
FR2750865B1 (fr) * | 1996-06-27 | 1998-12-04 | Rhone Merieux | Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2 |
US6051238A (en) * | 1996-12-20 | 2000-04-18 | Merck & Co., Inc. | Stabilizers for lyophilized mumps vaccines |
KR100768114B1 (ko) * | 1999-06-10 | 2007-10-17 | 메리알 | 애완 동물 및 스포츠용 동물을 위한 dna 백신 |
JP2002326924A (ja) * | 2001-05-07 | 2002-11-15 | Hayashibara Biochem Lab Inc | 洗顔料 |
ES2536322T3 (es) * | 2003-12-17 | 2015-05-22 | Wyeth Llc | Procedimiento para producir composiciones de VSR estables en almacenamiento |
WO2005066333A1 (en) * | 2003-12-30 | 2005-07-21 | Aventis Pasteur, Inc. | Stabilizing compositions for recombinant viruses |
US20060141483A1 (en) * | 2004-12-23 | 2006-06-29 | Calton Gary J | Stabilization of viral compositions |
-
2006
- 2006-09-15 WO PCT/US2006/035944 patent/WO2007035455A2/en active Application Filing
- 2006-09-15 ES ES06814694T patent/ES2373238T3/es active Active
- 2006-09-15 SI SI200631180T patent/SI1954308T1/sl unknown
- 2006-09-15 PL PL06814694T patent/PL1954308T3/pl unknown
- 2006-09-15 RS RS20110471A patent/RS51996B/en unknown
- 2006-09-15 ME MEP-2011-471A patent/ME01965B/me unknown
- 2006-09-15 US US11/522,211 patent/US8784843B2/en active Active
- 2006-09-15 DK DK06814694.3T patent/DK1954308T3/da active
- 2006-09-15 JP JP2008531340A patent/JP5275803B2/ja active Active
- 2006-09-15 CN CN2006800430291A patent/CN101312742B/zh active Active
- 2006-09-15 AT AT06814694T patent/ATE523207T1/de active
- 2006-09-15 EP EP06814694A patent/EP1954308B1/en active Active
- 2006-09-15 PT PT06814694T patent/PT1954308E/pt unknown
-
2011
- 2011-11-02 HR HR20110803T patent/HRP20110803T1/hr unknown
- 2011-12-02 CY CY20111101189T patent/CY1112490T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20110803T1 (hr) | 2011-11-30 |
CN101312742B (zh) | 2012-07-25 |
EP1954308A2 (en) | 2008-08-13 |
JP5275803B2 (ja) | 2013-08-28 |
PT1954308E (pt) | 2011-11-03 |
CY1112490T1 (el) | 2015-12-09 |
JP2009508866A (ja) | 2009-03-05 |
WO2007035455A3 (en) | 2007-07-26 |
RS51996B (en) | 2012-04-30 |
US8784843B2 (en) | 2014-07-22 |
ES2373238T3 (es) | 2012-02-01 |
US20100260796A1 (en) | 2010-10-14 |
WO2007035455A2 (en) | 2007-03-29 |
EP1954308B1 (en) | 2011-09-07 |
ME01965B (me) | 2012-04-30 |
ATE523207T1 (de) | 2011-09-15 |
DK1954308T3 (da) | 2011-10-24 |
CN101312742A (zh) | 2008-11-26 |
SI1954308T1 (sl) | 2011-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ME01965B (me) | Stabilizatori za vakcine osušene zamrzavanjem | |
MY150613A (en) | Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses | |
MX2009004862A (es) | Estabilizacion de vacunas por liofilizacion. | |
WO2009156405A8 (en) | Novel immunoadjuvant flagellin-based compounds and use thereof | |
PH12015500773A1 (en) | Methods and compositions for live attenuated viruses | |
PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
MY171210A (en) | Stabilized soluble pre-fusion rsv f polypeptides | |
MX2010003242A (es) | Volatiles vegetales. | |
EA201001491A1 (ru) | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов | |
WO2008054481A3 (en) | Improved inactivated influenza virus compositions | |
WO2007126816A3 (en) | Methods and compositions for vaccination of poultry | |
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
MX2009006178A (es) | Vacuna contra salmonela. | |
NZ591925A (en) | Adjuvant composition comprising a host defense peptide, an immunostimulatory sequence and a polyanionic polymer | |
GB0710529D0 (en) | Vaccine | |
MX2009010564A (es) | Compuestos de 5,6-dihidro-1h-piridin-2-ona. | |
WO2008134643A3 (en) | Trypanosoma antigens, vaccine compositions, and related methods | |
MX2020007945A (es) | Proteinas f del rsv estabilizadas y usos de las mismas. | |
MX2020001885A (es) | Formulaciones de daptomicina. | |
WO2008048344A3 (en) | Bacillus anthracis antigens, vaccine compositions, and related methods | |
GB201017519D0 (en) | Vaccines | |
MX2011008179A (es) | Peptidos para vacuna. | |
WO2012054907A3 (en) | Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections | |
WO2011032108A3 (en) | Formulation for room temperature stabilization of a live attenuated bacterial vaccine | |
PH12018500675A1 (en) | Stable live attenuated recombinant dengue vaccine |